StoneX Group Inc. Acquires New Position in Astera Labs, Inc. $ALAB

StoneX Group Inc. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, Holdings Channel reports. The fund bought 5,480 shares of the company’s stock, valued at approximately $496,000.

Several other hedge funds have also made changes to their positions in ALAB. Fred Alger Management LLC raised its position in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after buying an additional 179,638 shares during the period. Hoey Investments Inc. increased its stake in Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after acquiring an additional 1,121 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its position in Astera Labs by 21.6% in the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after purchasing an additional 2,624 shares during the period. Wealth Effects LLC purchased a new stake in Astera Labs in the second quarter valued at $242,000. Finally, Maryland State Retirement & Pension System lifted its stake in shares of Astera Labs by 37.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after purchasing an additional 1,906 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity

In related news, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief operating officer owned 1,599,750 shares in the company, valued at approximately $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the sale, the chief financial officer owned 192,297 shares in the company, valued at approximately $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 586,936 shares of company stock valued at $89,331,140. 12.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ALAB. Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Stifel Nicolaus boosted their price target on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. Finally, Cowen restated a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $188.17.

Astera Labs Trading Down 4.9%

Shares of NASDAQ ALAB opened at $167.08 on Wednesday. The stock has a market cap of $28.22 billion, a P/E ratio of 150.52, a PEG ratio of 3.27 and a beta of 1.51. The business’s fifty day simple moving average is $168.98 and its 200-day simple moving average is $152.61. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs’s revenue was up 103.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.